Arton - Studio
Dissolution volontaire – liquidationThe score of Arton - Studio shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2006
Change 2003 → 2006: Equity -5 % Total assets -57 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Arton - Studio's annual accounts
Filed annual accounts
- Year ended 30 Sep 2006filed on 13 Mar 2007
- Year ended 30 Sep 2005filed on 13 Mar 2007
- Year ended 30 Sep 2004filed on 13 Mar 2007
- Year ended 30 Sep 2003filed on 13 Sep 2004
- Year ended 30 Sep 2002filed on 02 Apr 2003
Arton - Studio's financial analysis
- Solvency25.6%sector median: 56.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Arton - Studio
Arton - Studio's publications in the Belgian Gazette
No Belgian Gazette publication known for this company.
Company number, VAT number and registered office
- Company number (CBE)
- 0437.352.511
- VAT number
- BE0437352511
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Incorporated
- 16 May 1989
- Registered office
- 9000 Ghent
- Latest accounts
- 2006 · filed on 13 Mar 2007
- Activity
- Manufacture of basic pharmaceutical products (NACE 2110001)
Arton - Studio has been based in Ghent since 1989, active in: manufacture of basic pharmaceutical products. For 2006, it reports a net profit of — and equity of 7,339 €; its revenue is not published. Its solvency stands at 25.6%, below the median of its sector (56.0%).
Companies similar to Arton - Studio
Same activity (NACE code), registered office in the same province, closest balance-sheet size.
- Studelco Manufacture of basic pharmaceutical products Geraardsbergen · balance sheet 17,230 €
- RPO NucleoGenesis Manufacture of basic pharmaceutical products Ghent · balance sheet 107,514 €
- Tulipa Grafische Communicatie Manufacture of basic pharmaceutical products Ninove · balance sheet 119,693 €
- Apcor R&M Manufacture of basic pharmaceutical products Ghent · balance sheet 5,677 €
- E.C.T. VAN Beersel Manufacture of basic pharmaceutical products Ghent · balance sheet 145,543 €
- Klima+ Service Manufacture of basic pharmaceutical products Nazareth-De Pinte · balance sheet 151,490 €
- Amalus Therapeutics Manufacture of basic pharmaceutical products Ghent · balance sheet 160,051 €
- Mayaku Pharmaceutical Development Manufacture of basic pharmaceutical products Ghent · balance sheet 170,483 €
Frequently asked questions about Arton - Studio
What is the revenue of Arton - Studio?
Arton - Studio files its accounts in a format where revenue is optional: it is not published for 2006.
What is the VAT number of Arton - Studio?
In Belgium, the VAT number is the company number prefixed with BE: BE0437352511 for Arton - Studio, if the company is VAT-registered. Its company number (CBE) is 0437.352.511.
Where is the registered office of Arton - Studio?
According to the CBE register, the registered office of Arton - Studio is in 9000 Ghent.
What is the equity of Arton - Studio?
At the close of the 2006 financial year, the equity of Arton - Studio amounts to 7,339 €, a solvency of 25.6% of total assets.
Who manages Arton - Studio?
The register lists 1 active mandates at Arton - Studio. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Arton - Studio
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →